Neomycin Sulfate Equivalent To Neomycin Base + Nystatin + Thiostrepton
62 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
62
Total Reports
4
Deaths Reported
650.0%
Death Rate
Active Ingredients
Neomycin Sulfate Equivalent To Neomycin BaseNystatinThiostrepton
Administration Routes
UnknownAuricular (Otic)TopicalOphthalmic
Species Affected
Dog 50
Cat 12
Most Affected Breeds
Domestic Shorthair 7
Unknown 4
Bulldog - French 3
Retriever - Golden 3
Boxer (German Boxer) 3
Dog (unknown) 3
Maltese 3
Chihuahua 3
Poodle - Toy 2
Terrier (unspecified) 2
Most Reported Reactions
Deafness 34
Emesis 8
Impaired hearing 4
Ataxia 4
Lack of efficacy - NOS 3
Ear canal disorder 3
Incorrect route of drug administration 3
Accidental exposure 3
Partial deafness 3
Anorexia 3
Behavioural disorder NOS 3
Otorrhoea 2
Outcome Breakdown
Outcome Unknown
41 (66.1%)
Recovered/Normal
7 (11.3%)
Recovered with Sequela
6 (9.7%)
Ongoing
4 (6.5%)
Died
3 (4.8%)
Euthanized
1 (1.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.